As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Previous studies have concluded that early intervention in dementia cases can increase patients' treatment options and ...

Recognizing the five critical signs of Alzheimer's final progression helps families understand what to expect and how to ...

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

We spoke to the first author of a new study that could challenge much of what we thought we knew about Alzheimer’s disease.

A recent study from UCLA identifies four distinct clusters of symptoms that can progress to Alzheimer's disease, offering new ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

It's been recognized for some time that Alzheimer's disease affects brain regions differently and that tau—a protein known to ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

Study offers patients the opportunity to try an experimental, non-drug therapy for Alzheimer's using an FDA-designated Breakthrough Device ATLANTA, July ...